Sliced Bread

Dough - Food

Apr 2, 2026
Owen Ensor, CEO of Meatly, explains cell‑cultivated meat timelines. Karina Zimmerfeldt, R&D leader at Mars Food & Nutrition, talks supply resilience and product strategy. Charles Banks, chef-turned-trends expert, maps consumer food shifts. Tom Cheesewright, futurist, offers 5/10/50-year forecasts. They discuss cultivated meat, ancient grains, insect and alternative proteins, AI-driven personalised nutrition and future supply challenges.
Ask episode
AI Snips
Chapters
Transcript
Episode notes
INSIGHT

Appetite Drugs Will Reshape Food Demand Fast

  • Next-generation GLP-1 drugs will likely change consumption patterns quickly and spur retail and product adjustments.
  • Charles Banks notes retailers already launching GLP-1 friendly convenience meals and expects targeted drug iterations to accelerate shifts.
ADVICE

Update Heritage Brands By Listening To Consumers

  • Listen to evolving consumer expectations rather than cling to heritage recipes unchanged.
  • Karina Zimmerfeldt argues stagnation is riskier than change and R&D must balance heritage with new sensorial experiences.
INSIGHT

Protein Alternatives Favor Ingredients Not Insect Shapes

  • Protein alternatives will come from precision fermentation, legumes and less-visible insect ingredients rather than insect-shaped dishes.
  • Tom Cheesewright cites insect flour in pizza and precision-fermented milk proteins as practical, lower-impact options.
Get the Snipd Podcast app to discover more snips from this episode
Get the app